Author

A. Adibekian

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 2 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 3 Approach:experimental assay· 3 Assay:proteomics· 2 Organism:human· 1 Organism:plant (other)· 1

Frequent Co-Authors

D. Abegg· 3 shared F. F. Faucher· 2 shared M. Bogyo· 2 shared S. Lovell· 2 shared D. A. Fidock· 1 shared E. Yeh· 1 shared F. Hackett· 1 shared H. S. Haniff· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersBiochemistry

D. Abegg

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

MicrobiologyCell Chemical BiologyPeer-reviewedSep 1, 2024

Mixed Alkyl/Aryl Phosphonates Identify Metabolic Serine Hydrolases as Antimalarial Targets

J. M. Bennett, S. K. Narwal, S. Kabeche…·M. Bogyo

The paper identifies mixed alkyl/aryl phosphonates as anti-malarial compounds that inhibit serine hydrolases with low resistance potential.

DOI 10.1016/j.chembiol.2024.07.006

plant (other)experimental assay

𝕏 PostBluesky

BiochemistrybioRxivFeb 17, 2023

Solid Phase Synthesis of Fluorosulfate Containing Macrocycles for Chemoproteomic Workflows

F. F. Faucher, D. Abegg, P. Ipock…·M. Bogyo

The paper describes a solid-phase synthesis method for creating macrocyclic peptides with fluorosulfate electrophiles, enabling chemoproteomic screening and target identification.

DOI 10.1002/ijch.202300020

proteomicsexperimental assay

𝕏 PostBluesky

BiochemistrybioRxivPreprintJun 27, 2020

Small molecules exploiting structural differences within microRNA-200 precursors family members reverse a type 2 diabetes phenotype

H. S. Haniff, X. Liu, L. Knerr…·M. D. Disney

The paper designs small molecules that target the structural differences in miR-200 precursor family members to selectively reverse a type 2 diabetes phenotype.

DOI 10.1101/2020.06.27.175281

humanproteomics

𝕏 PostBluesky